Live Breaking News & Updates on Ionis Pharmaceuticals Trading
Stay updated with breaking news from Ionis pharmaceuticals trading. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) posted its quarterly earnings data on Wednesday. The company reported ($0.87) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.00) by $0.13, Briefing.com reports. Ionis Pharmaceuticals had a negative net margin of 45.75% and a negative return on equity of 43.01%. The company had revenue […] ....
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) – Stock analysts at Zacks Research increased their Q1 2023 earnings per share (EPS) estimates for shares of Ionis Pharmaceuticals in a research report issued to clients and investors on Wednesday, April 19th. Zacks Research analyst K. Shah now forecasts that the company will earn ($1.00) per share […] ....
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has received a consensus rating of “Hold” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating on the company. The average […] ....
CIBC Asset Management Inc purchased a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 5,583 shares of the company’s stock, valued at approximately $207,000. A number of other hedge funds and other institutional investors have also recently modified their holdings of […] ....